RecruitingAccepts healthy volunteers
Collection of Blood for Multiple Collaborative Studies
University of California, San Francisco · NCT01336855
View Study & Apply (opens in a new tab)
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 2000
- US sites recruiting
- 1
- Study start
- January 1988
- Record last updated
- April 13, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study seeks to confidentially collect blood from HIV-positive individuals and HIV-negative controls to provide basic scientists with specimens for collaborative studies.
Conditions: HIV
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- HIV-1 antibody negative with similar characteristics to HIV-1 positive cohort
- HIV-positive subjects naive to antiretroviral therapy
- HIV-positive subjects stable on or off antiretroviral therapy for a minimum of 6 months
- Good venous access
- Able to provide informed consent
Exclusion Criteria
- Hemoglobin \< 9g/dl
- Hematocrit \< 27%
- Active treatment for cancer
- Hospitalization or IV antibiotic use within the last 4 months
- Immunosuppressive therapy within the last 4 months
Recruiting US locations
San Francisco General Hospital
San Francisco, CA 94110
Study contacts (from the official record)
- Rebecca Hoh, M.S., R.D. · 415-476-4082 · Rebecca.Hoh@ucsf.edu
- Viva Tai, MS. RD · 415-476-4082 · Viva.Tai@ucsf.edu
Similar studies in California
All healthy volunteers studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- Rialto, CA + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Lake Forest, CA + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Phase 1 Study of SBS-147 in Healthy Adults
Sparian Biosciences, Inc
- Location
- Cypress, CA
- Eligibility basics
- Ages 18–55